Medical Expulsive Therapy (MET) in adults with ureteral calculi: a prospective evaluation of patient-reported outcomes.

AIIMS Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•A. Written informed consent.
•B. Age more than or equal to 18 years.
•C. Newly diagnosed, single, unilateral, ureteral calculus diagnosed on non-contrast computed tomography.
•D. Stone size less than or equal to 10 mm.

•A. Fever, defined as axillary temperature 100Ã?Â° F or more, or a history of fever with chills and rigors.
•B. Ipsilateral renal angle tenderness on examination, or a bulky ipsilateral kidney with peri-renal fat stranding on non-contrast computed tomography suspicious of acute pyelonephritis.
•C. Active urinary tract infection (UTI) as confirmed on urine culture.
•D. Presence of synchronous ipsilateral renal pelvic and pelvic-ureteral junction stone, or bilateral ureteral calculi.
•E. Any previous intervention for the present calculus, including shock-wave lithotripsy (SWL), ureteroscopy (URS), ureteral stent placement, or percutaneous nephrostomy (PCN).
•F. Ureteral stone in an ectopic or malrotated kidney.
•G. Deranged renal parameters.
•H. Patients with a solitary kidney.
•I. Pregnancy.
•J. Immune-compromised state, including acquired immune-deficiency disease, immune-suppressant therapy, chemotherapy, and long-term steroid therapy.
•K. Not available for follow-up.

发起方